Authors: Al-Douahji, M Brugarolas, J Brown, PAJ Stehman-Breen, CO Alpers, CE Shankland, SJ

Citation: M. Al-douahji et al., The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy, KIDNEY INT, 56(5), 1999, pp. 1691-1699